HOME > News > Announcements > PRONULIFE® Effenergy by Glac Biotech Wins “Excellence Award – Innovative Product” at the 2025 TALAB Awards
PRONULIFE® Effenergy by Glac Biotech Wins “Excellence Award – Innovative Product” at the 2025 TALAB Awards
Glac Biotech’s functional probiotic ingredient PRONULIFE® Effenergy has been honored with the 2025 “Innovative Product – Excellence Award” by the Taiwan Lactobacillus Association (TALAB).
Among numerous submissions, Effenergy stood out for its precise functional positioning of energy utilization, post-exercise regulation, and daily vitality support, earning strong recognition from the expert panel.
■ A Function-Driven Design Built Around Core Needs
Effenergy is developed based on the core demands of the sports nutrition sector, integrating strain characteristics, energy-metabolism pathways, and physiological regulatory evidence to a formula optimized for everyday active individuals.
Its functional design emphasizes:
• Supporting energy production and physical recovery
• Reducing post-exercise load and fatigue accumulation
• Promoting sustained daily vitality
Through complementary strain interactions and coordinated mechanisms, Effenergy enhances overall metabolic modulation, forming a probiotic solution with clear and practical application scenarios.
■ Aligned With Global Trends in Precision Nutrition & Function-Specific Design
This year’s TALAB Innovation Award highlights the importance of connecting mechanisms, scientific validation, and real-world application.
Effenergy’s recognition reflects rising market demand for “Precision Nutrition × Function-Directed Formulation” within sports and performance nutrition.
Its R&D logic follows three core principles:
• Strain characteristics and mechanistic research as the design foundation
• Application-driven formulation aligned with consumer needs
• A focus on commercial viability and differentiated ingredient value
This approach is consistent with global probiotic research trends, demonstrating Effenergy’s strong mechanistic rationale and market relevance.
■ Empowering Partners With a More Competitive Ingredient Choice
Effenergy’s award not only affirms the ingredient’s technical strengths but also recognizes Glac Biotech’s ongoing efforts in microbiome research, strain-development platforms, and functional ingredient innovation.
For applications in sports nutrition, physical performance, and daily vitality, Effenergy enables brand partners to develop products that are:
• More differentiated
• Scientifically supported
• Easier for consumers to understand and trust
👉 Learn More｜PRONULIFE® Effenergy
🔗 Extended Reading
Taiwan’s Probiotic Innovation Boom! Ten Companies Awarded Innovative Product Honors — Functional Strains Driving the Next-Generation Health Market
(Global Bio & Investment Magazine)
Among numerous submissions, Effenergy stood out for its precise functional positioning of energy utilization, post-exercise regulation, and daily vitality support, earning strong recognition from the expert panel.
Effenergy is developed based on the core demands of the sports nutrition sector, integrating strain characteristics, energy-metabolism pathways, and physiological regulatory evidence to a formula optimized for everyday active individuals.
Its functional design emphasizes:
• Supporting energy production and physical recovery
• Reducing post-exercise load and fatigue accumulation
• Promoting sustained daily vitality
Through complementary strain interactions and coordinated mechanisms, Effenergy enhances overall metabolic modulation, forming a probiotic solution with clear and practical application scenarios.
This year’s TALAB Innovation Award highlights the importance of connecting mechanisms, scientific validation, and real-world application.
Effenergy’s recognition reflects rising market demand for “Precision Nutrition × Function-Directed Formulation” within sports and performance nutrition.
Its R&D logic follows three core principles:
• Strain characteristics and mechanistic research as the design foundation
• Application-driven formulation aligned with consumer needs
• A focus on commercial viability and differentiated ingredient value
This approach is consistent with global probiotic research trends, demonstrating Effenergy’s strong mechanistic rationale and market relevance.
Effenergy’s award not only affirms the ingredient’s technical strengths but also recognizes Glac Biotech’s ongoing efforts in microbiome research, strain-development platforms, and functional ingredient innovation.
For applications in sports nutrition, physical performance, and daily vitality, Effenergy enables brand partners to develop products that are:
• More differentiated
• Scientifically supported
• Easier for consumers to understand and trust
Taiwan’s Probiotic Innovation Boom! Ten Companies Awarded Innovative Product Honors — Functional Strains Driving the Next-Generation Health Market
(Global Bio & Investment Magazine)
-
2023.3.23 Glac Biotech’s Flagship Probiotic CP-9 Reaches New Heights With Breakthrough Patent in Neonatal Jaundice Resea
-
2024.3.29 Glac Biotech’s Totipro® PE0301 Wins NutraIngredients Award, Reinforcing Global Leadership in Postbiotics
-
Totipro® PE0401, the Postbiotic That Brings Health Within Reach — Making Daily Nutrition Simple and Joyful
-
2023.12.15 Glac Biotech’s PRONULIFE® LvUCare Wins Top Innovation Award from the Lactic Acid Bacteria Association